Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth - GBI Research Reports

Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth

Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth - GBI Research Reports
Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth
Published Oct 01, 2010
114 pages — Published Oct 01, 2010
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research has released its Chemical research, 'Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth'. The report provides a detailed insight into the global Active Pharmaceutical Ingredients (APIs) market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in major regions of the world. The report contains market forecasts, product type analysis, drivers and restraints, analysis of the therapeutic categories and a market share analysis of the major producers in the important geographical markets of the world. In addition, it includes market forecasts, product type analysis and therapeutic categories analysis of the APIs in major countries of the world. Overall, the report presents a comprehensive analysis of the global API market covering all the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

North America and Europe together account for more than 60% share in the global API market revenue. Asia-Pacific is the fastest growing API market in the world. The global API demand is led by China, India and Brazil. The innovator APIs are increasingly losing market share to generic sector APIs. On the basis of synthesis route, the synthetic APIs continue to dominate the global revenues. However, the growth in biotech APIs is expected to be faster in the forecast period.

The global API sales revenue was $91 billion in 2009 and is expected to grow at a CAGR of 5.9% from 2010 to 2015. The growth will be driven by the rise in demand of generic sector drugs and biological drugs. The recovery from economic slowdown will help the global API market to grow. The global API sales revenue is expected to reach $126.3 billion in 2015.

Scope

- Market revenue data for APIs from 2005 to 2009 and forecast for six years to 2015.
- API markets in key regions: North America, Europe, Asia-Pacific and South and Central America.
- API markets in key countries: the US, Canada, Germany, the UK, France, Italy, Spain, Japan, China, India, Mexico and Brazil.
- Drivers of the API market such as growth in generic drugs and biotech drugs, and restraints such as economic slowdown and patent expiries, for the global market as well as for regional markets.
- Information on the competitive landscape with the shares of leading companies such as Pfizer Inc, AstraZeneca International, GlaxoSmithKline Pharmaceuticals, Sanofi Aventis and Novartis.
- Analysis of API revenue by product type in the global market, in key regions and countries
- Analysis of API revenue by therapeutic category in the key countries.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the global APIs market.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key companies best positioned to take advantage of the emerging market opportunities.
- Benchmark different geographies by the historic and forecasted growth of the APIs market.
- Identify macro and micro-economic trends shaping and driving the global APIs market.

  
Source:
Document ID
GBICH0027MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
1 Table of Contents48
1.1 List of Tables82
1.2 List of Figures102
2 Introduction 121
2.1 GBI Report Coverage121
3 Global API Market1310
3.1 Global API Industry Structure131
3.2 Global API Industry Challenges141
3.2.1 Maturity of the Market in Developed Regions Restricts the Global API Revenue Growth141
3.2.2 High Cost of New Drug Development Becomes a Hurdle to Innovation141
3.2.3 Highly Fragmented Nature of Market Leads to Intense Competition and Price Decline141
3.2.4 Regulatory Challenges Delay the Launch of Drugs141
3.3 Global API Market Overview141
3.4 Global API Market Revenue Analysis and Forecasts to 2015152
3.5 Global API Market Revenue Share Analysis by Product Type and Forecasts to 2015171
3.5.1 Global API Revenue Share Analysis by Product Type Based on Synthesis Routes and Forecasts to 2015181
3.5.2 Global API Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015191
3.6 Global API Revenue Share Analysis by Region and Forecasts to 2015201
Global API Market Competitive Landscape212
4 North America API Market2319
4.1 North America API Market Overview231
4.2 North America API Market Drivers231
4.2.1 Growth in the Generic Sector is Leading the Overall Growth in Demand for APIs in the Region231
4.2.2 Increasing Focus on Biological Drugs Contributes to the Growth of API Demand in the Region231
4.2.3 The Rising Incidence of Lifestyle and Older Age Diseases is Giving Rise to API Demand in the Region 231
4.2.4 Growth in Oncology is one of the Major Contributing Factors to the Growth of APIs in the Region231
4.2.5 Increasing Focus on High Potency APIs Helps the Market Growth241
4.3 North America API Market Restraints241
4.3.1 The Economic Downturn has Restricted the Growth of API Demand in the Region241
4.3.2 Decreasing Focus on the Innovator Sector Limits the Growth of North American API Market241
4.3.3 Patent Expiry of Some Blockbuster Molecules Will Adversly Affect the Growth of API Market in the Region241
4.3.4 Rising Competition from China and India is Creating Price Pressure in the North American Market241
4.4 North America API Market Revenue Analysis and Forecasts to 2015252
4.5 North America API Market Revenue Share Analysis by Product Type and Forecasts to 2015271
4.5.1 North America API Revenue Share Analysis by Product Type Based on Synthesis Routes and Forecasts to 2015271
North America API Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015281
4.6 North America API Market Revenue Share Analysis by Country and Forecasts to 2015291
4.7 North America API Market Competitive Landscape301
4.8 The US API Market311
4.8.1 The US API Market Overview311
4.8.2 The US API Market Revenue Analysis and Forecasts to 2015321
4.8.3 The US API Market Revenue Share Analysis by Product Type and Forecasts to 2015331
4.8.3.1 The US API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015331
4.8.3.2 The US API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015341
4.8.4 The US API Market Revenue Share Analysis by Therapeutic Category351
4.9 Canada API Market361
4.9.1 Canada API Market Overview361
4.9.2 Canada API Market Revenue Analysis and Forecasts to 2015371
4.9.3 Canada API Market Revenue Share Analysis by Product Type and Forecasts to 2015381
4.9.3.1 Canada API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015381
4.9.3.2 Canada API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015391
4.9.4 Canada API Market Revenue Share Analysis by Therapeutic Category402
5 Europe API Market4231
5.1 Europe API Market Overview421
5.2 Europe API Market Drivers421
5.2.1 Rising Demand in the Generic Sector Forces the API Market to Grow in the Region421
5.2.2 Increasing Focus on Biopharmaceuticals Encourages the Growth in the API Market421
5.2.3 Rising Incidences of Lifestyle Diseases and Older Age Diseases in the Region Enable the Growth in API Market421
5.2.4 Growth in Oncology Contributes to the API Market growth in the Region421
5.2.5 Increasing Focus on HPAPI Helps the Overall API Revenue Growth421
5.2.6 Increasing Number of Development Projects in Therapeutic Peptide Area431
5.3 Europe API Market Restraints431
5.3.1 The Economic Slowdown is Hampering the Overall Pharmaceutical Market in the Region431
5.3.2 Large Number of Patent Expiries Will Lead to Reduced Growth in the Region s API Market431
5.3.3 Decreasing Focus on Innovator Drug Sector Restricts the Overall API Market Revenue431
5.3.4 Price Erosion in the API Market is Hindering the Revenue Growth431
5.4 Europe API Market Revenue Analysis and Forecasts to 2015441
5.5 Europe API Market Revenue Share Analysis by Product Type and Forecasts to 2015451
5.5.1 Europe API Revenue Share Analysis by Product Type Based on Synthesis Routes and Forecasts to 2015451
5.5.2 Europe API Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015461
5.6 Europe API Market Revenue Share Analysis by Country and Forecasts to 2015471
Europe API Market Competitive Landscape481
5.8 Germany API Market491
5.8.1 Germany API Market Overview491
5.8.2 Germany API Market Revenue Analysis and Forecasts to 2015501
5.8.3 Germany API Market Revenue Share Analysis by Product Type and Forecasts to 2015511
5.8.3.1 Germany API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015511
5.8.3.2 Germany API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015521
Germany API Market Revenue Share Analysis by Therapeutic Category531
5.9 The UK, API Market541
The UK, API Market, Overview541
5.9.2 The UK API Market Revenue Analysis and Forecasts to 2015541
5.9.3 The UK API Market Revenue Share Analysis by Product Type and Forecasts to 2015551
5.9.3.1 The UK API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015551
5.9.3.2 The UK API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015561
5.9.4 The UK API Market Revenue Share Analysis by Therapeutic Category571
5.10 France API Market581
France API Market Overview581
5.10.2 France API Market Revenue Analysis and Forecasts to 2015582
5.10.3 France Market Revenue Share Analysis by Product Type and Forecasts to 2015601
5.10.3.1 France API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015601
5.10.3.2 France API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015611
5.10.4 France API Market Revenue Share Analysis by Therapeutic Category621
5.11 Italy API Market631
5.11.1 Italy API Market Overview631
5.11.2 Italy API Market Revenue Analysis and Forecasts to 2015632
5.11.3 Italy API Market Revenue Share Analysis by Product Type and Forecasts to 2015651
5.11.3.1 Italy API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015651
5.11.3.2 Italy API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015661
5.11.4 Italy API Market Revenue Share Analysis by Therapeutic Category671
5.12 Spain API Market681
5.12.1 Spain API Market Overview681
5.12.2 Spain API Market Revenue Analysis and Forecasts to 2015691
5.12.3 Spain API Market Revenue Share Analysis by Product Type and Forecasts to 2015701
5.12.3.1 Spain API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015702
5.12.4 Spain API Market Revenue Share Analysis by Therapeutic Category721
6 Asia-Pacific API Market7323
6.1 Asia-Pacific API Market Overview731
6.2 Asia-Pacific API Market Drivers731
6.2.1 Rapidly Growing Economies of China and India Favour the Growth in the Region s API Market Revenue731
6.2.2 The Booming Generic Drug Sector is Leading the Growth of API Market in Asia Pacific731
6.2.3 Increasing Demand of Innovator Drugs Contributes to the Revenue Growth in the Region s API Market731
6.2.4 Growth in the Development of Biotech Drugs Helps API Market Revenue to Grow in the Region741
6.2.5 Peptide APIs Offer Growth Opportunities to the Asia-Pacific s API Market741
6.2.6 Government s Plan to Develop Multi-level Insurance System in China is Set to Boost the Growth of the API Market741
6.3 Asia-Pacific API Market Restraints741
6.3.1 Rising Competition is Leading to Price Erosion Which Affects the Revenue Growth in the API Market of the Region741
6.3.2 Fluctuations in the Prices Acts as a Hurdle in the Revenue Growth741
6.3.3 Surplus Capacity May Emerge as a Challenge for Producers in China and India741
6.3.4 The Global Economic Slowdown has Reduced the Demand in the API Market751
6.4 Asia-Pacific API Market Revenue Analysis and Forecasts to 2015752
6.5 Asia-Pacific API Market Revenue Share Analysis by Product Type and Forecasts to 2015771
6.5.1 Asia-Pacific, API Revenue Share Analysis by Product Type Based on Synthesis Routes and Forecasts to 2015771
6.5.2 Asia-Pacific API Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015781
6.6 Asia-Pacific API Market Revenue Share Analysis by Country and Forecasts to 2015791
6.7 Asia-Pacific API Market Competitive Landscape801
6.8 Japan API Market811
6.8.1 Japan API Market Overview811
6.8.2 Japan API Market Revenue Analysis and Forecasts to 2015811
6.8.3 Japan API Market Revenue Share Analysis by Product Type and Forecasts to 2015821
6.8.3.1 Japan API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015821
6.8.3.2 Japan API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015831
6.8.4 Japan API Market Revenue Share Analysis by Therapeutic Category841
6.9 China API Market851
6.9.1 China API Market Overview851
6.9.2 China API Market Revenue Analysis and Forecasts to 2015861
6.9.3 China API Market Revenue Share Analysis by Product Type and Forecasts to 2015871
6.9.3.1 China API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015871
6.9.3.2 China API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015881
6.9.4 China API Market Revenue Share Analysis by Therapeutic Category891
India API Market901
6.10.1 India API Market Overview901
India API Market Revenue Analysis and Forecasts to 2015911
6.10.3 India API Market Revenue Share Analysis by Product Type and Forecasts to 2015921
6.10.3.1 India API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 2015921
6.10.3.2 India API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015931
6.10.4 India API Market Revenue Share Analysis by Therapeutic Category942
7 South and Central America API Market9616
South and Central America API Market Overview961
7.2 South and Central America API Market Drivers961
7.2.1 Rapidly Growing Brazilian Economy Boosts the Overall API Market Growth in the Region961
7.2.2 Growth in the Generic Sector Augments the Overall API Market Growth961
7.2.3 Growth in Biotechnology Adds Significantly to the Growth of API Market in the Region961
7.2.4 Increasing Ageing Population, Changing Demographics and Lifestyle Helps Growth in the API Market of the Region961
7.3 South and Central America API Market Restraints 961
7.3.1 Economic Slowdown has Hampered the Growth of Pharmaceutical Market in the Region961
7.3.2 The Slowdown in the Innovator Drugs Market in the Region has Affected the Overall API Market Growth971
7.3.3 Declining Prices Restricts the Revenue Growth of the API Market in the Region971
South and Central America API Market Revenue Analysis and Forecasts to 2015971
7.5 South and Central America API Market Revenue Share Analysis by Product Type and Forecasts to 2015981
7.5.1 South and Central America API Revenue Share Analysis by Product Type Based on Synthesis Routes and Forecasts to 2015981
South and Central America API Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 2015991
7.6 South and Central America API Market Revenue by Country and Forecasts to 20151001
7.7 South and Central America API Market Competitive Landscape1011
7.8 Mexico API Market1011
7.8.1 Mexico API Market Overview1011
7.8.2 Mexico API Market Revenue Analysis and Forecasts to 20151021
7.8.3 Mexico API Market Revenue Share Analysis by Product Type and Forecasts to 20151031
7.8.3.1 Mexico API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 20151031
7.8.3.2 Mexico API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 20151041
7.8.4 Mexico API Market Revenue Share Analysis by Therapeutic Category1051
7.9 Brazil API Market1061
7.9.1 Brazil API Market Overview1061
7.9.2 Brazil API Market Revenue Analysis and Forecasts to 20151071
7.9.3 Brazil API Market Revenue Share Analysis by Product Type and Forecasts to 20151081
7.9.3.1 Brazil API Market Revenue Share Analysis by Product Type Based on Synthesis Route and Forecasts to 20151081
7.9.3.2 Brazil API Market Revenue Share Analysis by Product Type Based on Customer Base and Forecasts to 20151091
7.9.4 Brazil API Market Revenue Share Analysis by Therapeutic Category1102
8 Appendix1123
8.1 Market Definitions1121
8.2 Abbreviations1121
8.3 Methodology1122
8.3.1 Coverage1121
8.3.2 Secondary Research1131
8.3.3 Primary Research1131
8.3.4 Expert Panel Validation1131
8.4 Contact Us1131
8.5 About GBI Research1131
8.6 Disclaimer1141

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth" Oct 01, 2010. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Active-Pharmaceutical-Ingredients-APIs-Market-to-2015-Rise-in-the-Generic-and-Biotech-Sector-will-Sustain-Growth-2115-88>
  
APA:
GBI Research Reports. (2010). Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth Oct 01, 2010. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Active-Pharmaceutical-Ingredients-APIs-Market-to-2015-Rise-in-the-Generic-and-Biotech-Sector-will-Sustain-Growth-2115-88>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.